Cedar Wealth Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-498
Closed -$112K 301
2022
Q3
$112K Hold
498
0.06% 121
2022
Q2
$121K Sell
498
-1,707
-77% -$418K 0.06% 130
2022
Q1
$533K Buy
2,205
+217
+11% +$49.9K 0.22% 72
2021
Q4
$447K Buy
1,988
+1,939
+3,957% +$409K 0.18% 84
2021
Q3
$10K Hold
49
﹤0.01% 227
2021
Q2
$12K Hold
49
0.01% 227
2021
Q1
$12K Hold
49
0.01% 204
2020
Q4
$11K Hold
49
0.01% 194
2020
Q3
$12K Hold
49
0.01% 184
2020
Q2
$12K Sell
49
-54
-52% -$12.3K 0.01% 180
2020
Q1
$21K Buy
103
+49
+91% +$10.7K 0.01% 158
2019
Q4
$13K Hold
54
0.01% 137
2019
Q3
$10K Buy
+54
New +$10.4K 0.01% 129

Other funds holding AMGN

Cedar Wealth Management's AMGN Position: Q4 2022 in Review

Cedar Wealth Management sold out of Amgen (AMGN) in Q4 2022, closing a stake of 498 shares — an estimated $112K sold.

Cedar Wealth Management first reported a position in AMGN in Q3 2019 and held it in 13 quarters. The position peaked at $533K in Q1 2022. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Cedar Wealth Management reported no remaining Amgen position as of Q4 2022 after selling out during the quarter.
  • Cedar Wealth Management sold 498 Amgen shares in Q4 2022, an estimated $112K.
  • Cedar Wealth Management first reported a position in Amgen in Q3 2019 and held it in 13 quarters.
  • Cedar Wealth Management's Amgen position peaked at $533K in Q1 2022.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Cedar Wealth Management's 13F filing for Q4 2022, filed 14 Feb 2023.